There are 2789 resources available
449P - Homologous recombination repair gene mutations predict the efficacy of immune checkpoint inhibitors therapy in colorectal cancer
Presenter: Yan Lin
Session: ePoster Display
450P - Efficacy and safety of pyrotinib-based therapy in HER2-positive metastatic colorectal and gastric cancer: A retrospective study
Presenter: qian Li
Session: ePoster Display
452P - Predicting response to bevacizumab in colorectal cancer by integrating radiomics to clinical and genomic features
Presenter: Gianluca Milanese
Session: ePoster Display
453P - Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centre
Presenter: David Lau
Session: ePoster Display
454P - CCR5/CCL5 gene expression in colorectal cancer (CRC): Comprehensive profiling and clinical value
Presenter: Francesca Battaglin
Session: ePoster Display
455P - Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Presenter: Manuel Valladares-Ayerbes
Session: ePoster Display
262P - Pattern of failure and treatment results in triple-negative breast cancer patients
Presenter: Sherif Farouk El Zawawy
Session: ePoster Display
263P - Predicting bevacizumab efficacy in mTNBC
Presenter: Heba Bakri
Session: ePoster Display